Edition:
United Kingdom

Novartis AG (NOVN.S)

NOVN.S on Virt-X Level 1

76.16CHF
23 May 2018
Change (% chg)

CHF-0.52 (-0.68%)
Prev Close
CHF76.68
Open
CHF76.48
Day's High
CHF76.58
Day's Low
CHF76.02
Volume
6,237,957
Avg. Vol
5,617,720
52-wk High
CHF88.30
52-wk Low
CHF74.22

Select another date:

Thu, May 24 2018

Novartis receives EU approval for biosimilar Zessly

ZURICH Novartis said its Sandoz division received approval from the European Commission for its biosimilar Zessly (infliximab) in gastroenterological, rheumatological and dermatological diseases.

Novartis receives EU approval for biosimilar Zessly

ZURICH, May 24 Novartis said its Sandoz division received approval from the European Commission for its biosimilar Zessly (infliximab) in gastroenterological, rheumatological and dermatological diseases.

BRIEF-Novartis, Amgen Announce FDA Approval Of Aimovig Treatment For Migraine Prevention

* NOVARTIS AND AMGEN ANNOUNCE FDA APPROVAL OF AIMOVIG™ (ERENUMAB-AOOE), A NOVEL TREATMENT DEVELOPED SPECIFICALLY FOR MIGRAINE PREVENTION

FDA names drugmakers likely blocking access to branded drug samples

May 17 The U.S. Food and Drug Administration on Thursday named drugmakers including Celgene Corp, Mylan NV, Gilead Sciences and Novartis AG for potentially blocking access to samples of their products to delay generic competition.

Novartis top lawyer exits over Trump attorney deal 'mistake'

ZURICH Novartis's top lawyer quit on Wednesday over a $1.2 million (890,419 pounds) contract he co-signed with U.S. President Donald Trump's personal attorney, a deal the Swiss drugmaker's ex-CEO also said was a mistake. | Video

Novartis top lawyer exits over Trump attorney deal 'mistake'

ZURICH Novartis's top lawyer quit on Wednesday over a $1.2 million contract he co-signed with U.S. President Donald Trump's personal attorney, a deal the Swiss drugmaker's ex-CEO also said was a mistake. | Video

UPDATE 4-Novartis top lawyer exits over Trump attorney deal 'mistake'

* CEO highlights pipeline strength, scope for bolt-on M&A (Adds comment from former CEO, recasts)

Novartis ex-CEO says regrets hiring, not firing Trump lawyer

ZURICH Ex-Novartis Chief Executive Joe Jimenez regrets rushing into a $100,000-per-month consulting contract with U.S. President Donald Trump's personal lawyer but said post-election uncertainty over the administration's healthcare ideas put pressure on the Swiss drugmaker to sign a deal quickly.

Novartis ex-CEO says regrets hiring, not firing Trump lawyer

ZURICH Ex-Novartis Chief Executive Joe Jimenez regrets rushing into a $100,000-per-month (74,280 pounds) consulting contract with U.S. President Donald Trump's personal lawyer but said post-election uncertainty over the administration's healthcare ideas put pressure on the Swiss drugmaker to sign a deal quickly.

UPDATE 1-Novartis ex-CEO says regrets hiring, not firing Trump lawyer

ZURICH, May 16 Ex-Novartis Chief Executive Joe Jimenez regrets rushing into a $100,000-per-month consulting contract with U.S. President Donald Trump's personal lawyer but said post-election uncertainty over the administration's healthcare ideas put pressure on the Swiss drugmaker to sign a deal quickly. "There should have been more due diligence," Jimenez said in an interview with Reuters on Wednesday.

Select another date: